about
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.Anticancer effects of anti-CD47 immunotherapy in vivoToll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cellsLurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity
P50
description
researcher (ORCID 0000-0002-2930-8573)
@en
wetenschapper
@nl
name
Kristina Iribarren
@en
Kristina Iribarren
@nl
type
label
Kristina Iribarren
@en
Kristina Iribarren
@nl
prefLabel
Kristina Iribarren
@en
Kristina Iribarren
@nl
P31
P496
0000-0002-2930-8573